Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 32,300 shares, a growth of 28.7% from the January 15th total of 25,100 shares. Based on an average trading volume of 246,000 shares, the days-to-cover ratio is currently 0.1 days.
Bioasis Technologies Trading Down 20.5 %
Shares of OTCMKTS BIOAF opened at $0.02 on Tuesday. The stock has a market capitalization of $1.69 million, a PE ratio of -0.71 and a beta of 0.29. The stock's fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.10. Bioasis Technologies has a 12-month low of $0.02 and a 12-month high of $0.23.
Get
Bioasis Technologies alerts:
Bioasis Technologies Company Profile
(Get Rating)
biOasis Technologies, Inc operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier.
See Also
- Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
- Should Medtronic's Recent Colibri Patent Controversy Concern You?
- Checkpoint Software Helps Cyber Security Stocks Bottom
- Under Armour Stock, Gap and Crap, Here's Why
- Is Chevron Positioned To Take Energy Sector Leadership?
- What Does the Consumer Price Index Measure?
Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
綠洲生物科技有限公司(BiOasis Technologies Inc.)是1月份空頭股數大幅增長的目標。截至1月31日,空頭股數共有32,300股,較1月15日的25,100股增長28.7%。以24.6萬股的平均成交量計算,目前天數與回補比率為0.1天。
BiOASIS技術公司股價下跌20.5%
週二,OTCMKTS BIOAF的股價開盤報0.02美元。該股市值為169萬美元,本益比為-0.71,貝塔係數為0.29。該股的50日簡單移動均線為0.05美元,其200日簡單移動均線為0.10美元。BiOasis Technologies的12個月低點為0.02美元,12個月高位為0.23美元。
到達
BiOASIS技術警報:
BiOASIS技術公司簡介
(獲取評級)
BiOasis Technologies,Inc.是一家生物製藥公司。它專注於神經疾病和障礙的診斷和治療的研究和開發,如腦癌、神經退行性疾病和代謝障礙。它的產品包括作為其專有載體的Transcend計劃、p97和跨越血腦屏障的顯像劑。
另請參閱
- 免費獲取StockNews.com關於BiOASIS技術的研究報告(BIOAF)
- 美敦力最近的Colibri專利爭議是否應該引起您的關注?
- Checkpoint軟體幫助網路安全類股觸底
- 在裝甲庫存、缺口和垃圾下,這就是為什麼
- 雪佛龍做好了引領能源行業的準備嗎?
- 消費者物價指數衡量的是什麼?
接受《BiOASIS技術日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞和分析師對BiOasis Technologies及相關公司的評級的每日摘要。